Read More Pharma Industry News Biogen strikes $600m deal with Pfizer for promising schizophrenia drug Biogen, a leading US biotechnology firm, has reached a significant agreement to acquire Pfizer’s neurology drug candidate, PF-04958242,… bySrinathMarch 12, 2018
